🇺🇸 Regular water, tamsulosin, Dutasteride in United States

FDA authorised Regular water, tamsulosin, Dutasteride on 21 December 2010

Marketing authorisations

FDA — authorised 21 December 2010

  • Application: ANDA090095
  • Marketing authorisation holder: BARR
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 26 February 2014

  • Application: ANDA202509
  • Marketing authorisation holder: PH HEALTH
  • Local brand name: DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 November 2015

  • Application: ANDA202808
  • Marketing authorisation holder: ACTAVIS LABS FL INC
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 November 2015

  • Application: ANDA204705
  • Marketing authorisation holder: PHARMOBEDIENT
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 November 2015

  • Application: ANDA202975
  • Marketing authorisation holder: ACTAVIS LABS FL INC
  • Local brand name: DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 November 2015

  • Application: ANDA200899
  • Marketing authorisation holder: CHARTWELL
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 November 2015

  • Application: ANDA202530
  • Marketing authorisation holder: RISING
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 November 2015

  • Application: ANDA204262
  • Marketing authorisation holder: ONESOURCE SPECIALTY
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 November 2015

  • Application: ANDA202660
  • Marketing authorisation holder: AUROBINDO PHARMA LTD
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 23 November 2015

  • Application: ANDA202204
  • Marketing authorisation holder: HIKMA
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 17 March 2016

  • Application: ANDA206373
  • Marketing authorisation holder: ACELLA
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 14 June 2016

  • Application: ANDA203241
  • Marketing authorisation holder: PHARMOBEDIENT
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 21 October 2016

  • Application: ANDA206574
  • Marketing authorisation holder: ASCENT PHARMS INC
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 7 April 2017

  • Application: ANDA204376
  • Marketing authorisation holder: ADAPTIS
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 4 October 2017

  • Application: ANDA204373
  • Marketing authorisation holder: ZYDUS LIFESCIENCES
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 13 October 2017

  • Application: ANDA207935
  • Marketing authorisation holder: HERITAGE PHARMS INC
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 21 November 2017

  • Application: ANDA209909
  • Marketing authorisation holder: HUMANWELL PURACAP
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 22 June 2018

  • Application: ANDA208227
  • Marketing authorisation holder: STRIDES PHARMA
  • Local brand name: DUTASTERIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 18 July 2024

  • Application: ANDA213300
  • Marketing authorisation holder: AUROBINDO PHARMA
  • Local brand name: DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is Regular water, tamsulosin, Dutasteride approved in United States?

Yes. FDA authorised it on 21 December 2010; FDA authorised it on 26 February 2014; FDA authorised it on 20 November 2015.

Who is the marketing authorisation holder for Regular water, tamsulosin, Dutasteride in United States?

BARR holds the US marketing authorisation.